Zobrazeno 1 - 5
of 5
pro vyhledávání: '"R I, Iatsyshyn"'
Autor:
I S, Lisnians'ka, R I, Iatsyshyn
Publikováno v:
Likars'ka sprava. (4)
The study involved 85 patients with chronic pyelonephritis in age from 26 to 62 years. All patients determined C-reactive protein (CRP), interleukin 6 and tumor necrosis factor-alpha in the blood and urine by standard techniques. With the simultaneou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::03da356500f5258b3e74e24f892c9781
https://pubmed.ncbi.nlm.nih.gov/25095688
https://pubmed.ncbi.nlm.nih.gov/25095688
Autor:
Ie M, Neĭko, R I, Iatsyshyn
Publikováno v:
Likars'ka sprava. (1)
Analyzes in the paper are chief pharmacological effects of pentoxifylline; the necessity is substantiated of its prescription in a combined therapy of systemic scleroderma (SSD). As many as 220 SSD patients on an in-patient care were examined. Apart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d8947ae6845400e0cc21f0ca2acdaff
https://pubmed.ncbi.nlm.nih.gov/11944397
https://pubmed.ncbi.nlm.nih.gov/11944397
Autor:
Ie M, Neĭko, R I, Iatsyshyn
Publikováno v:
Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994). 48(1)
The purpose of a research was to define the levels of interleukin-1 (IL-1) and interleukin-2 (IL-2) in patients with systemic scleroderma (SSc) and to analyse their dependence on the course of the illness. 75 patients with SSc and 20 apparently healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::56dcbdfb1330f87271f915428a51512b
https://pubmed.ncbi.nlm.nih.gov/11928633
https://pubmed.ncbi.nlm.nih.gov/11928633
Publikováno v:
Likars'ka sprava. (1)
Blood serum concentration of osteocalcin was studied in 53 patients with rheumatoid arthritis. Osteocalcin (noncollagenous protein of bony tissue) is a marker of bony tissue formation known to be of high informative value. There were no significant d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6684ae87f05862f733963b36c185785f
https://pubmed.ncbi.nlm.nih.gov/10878971
https://pubmed.ncbi.nlm.nih.gov/10878971
Publikováno v:
Likars'ka sprava. (7-8)
Aetymizolum was studied for its efficacy in the treatment of patients with osteoarthrosis. The results obtained suggest that aethymizolum is capable of correcting the levels of glycosaminoglucans in the patients' blood serum. With the content of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::70566cab495b1e4a31b01697c6b55357
https://pubmed.ncbi.nlm.nih.gov/7900360
https://pubmed.ncbi.nlm.nih.gov/7900360